Abstract
Transforming growth factor-β (TGF-β) can act as a multi-functional regulator of both cell growth and differentiation. Three isoforms of TGF-βs, namely TGF-β1 TGF-β2 and TGF-β3, have been identified in human tissues. Previously we reported the expression of TGF-β isoforms in normal human skin. However little is known about the role of TGF-β isoforms in the pathogenesis of psoriasis. Using the TGF-β precursor-specific antibodies to strengthen the specificity, we studied the immunohistochemical distribution of TGF-βs 1–3 in psoriatic skin. TGF-β2, which was found in the intercellular space of all the layers of the epidermis in normal human skin, was decreased in the psoriatic epidermis. The intensity of immunoreactivity has the tendency to decrease in the lower epidermis rather than in the upper epidermis of the transitional lesion. In contrast, TGF-β3 was present in the subepidermal area of the psoriatic skin as in the normal human skin. TGF-β1 was observed in neither epidermis nor dermis in both normal and psoriatic skin. Since TGF-β is a potent growth inhibitor for human keratinocytes, the decrease of TGF-β2 in the epidermis of psoriatic skin may contribute to epidermal hyperplasia, a hallmark of psoriasis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
